Data / Form D filings / BigHat Biosciences, Inc.
BigHat Biosciences, Inc.: Form D filings
BigHat Biosciences, Inc., a biotechnology company in San Mateo, CA, filed 5 Form D notices with the SEC between 2019 and 2026. The latest, on October 26, 2026, reports $75.1 million sold of a $80 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1900 ALAMEDA DE LAS PULGAS SUITE 400, San Mateo, CA, 94403
- Phone
- (857) 928-5232
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1797256
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | New notice | $79,999,947 | $75,141,086 | $4,858,861 | 29 | Jul 17, 2026 | sec.gov |
| Apr 28, 2025 | Amendment | $124,105,981 | $124,105,981 | 40 | Jun 30, 2022 | sec.gov | |
| Oct 3, 2022 | New notice | $80,000,006 | $79,999,904 | $102 | 27 | Jun 30, 2022 | sec.gov |
| Feb 12, 2021 | New notice | $18,999,988 | $18,834,498 | $165,490 | 6 | Jan 28, 2021 | sec.gov |
| Dec 19, 2019 | New notice | $5,302,511 | $5,302,511 | 12 | Oct 22, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peyton Greenside | Executive Officer, Director | |
| Vineeta Agarwala | Director | |
| Robert Chess | Director | |
| Francisco Gimenez | Director | |
| Andrew Conrad | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BigHat Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.